Abstract
The identification of effector proteins delivered into mammalian host cells by bacterial pathogens possessing syringelike nanomachines is an important step toward understanding the mechanisms underlying the virulence of these pathogens. In this chapter, we describe a method based on mammalian tissue culture infection models where incubation with a nonionic detergent (Triton X-100) enables solubilization of host cell membranes but not of bacterial membranes. This allows the isolation of a Triton-soluble fraction lacking bacteria but enriched in proteins present in the host cell cytoplasm and plasma membrane. Using appropriate controls, this fraction can be probed by immunoblotting for the presence of bacterial effector proteins delivered into host cells.
Similar content being viewed by others
References
Costa TR, Felisberto-Rodrigues C, Meir A, Prevost MS, Redzej A, Trokter M, Waksman G (2015) Secretion systems in Gram-negative bacteria: structural and mechanistic insights. Nat Rev Microbiol 13:343–359
Sory MP, Cornelis GR (1994) Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol Microbiol 14:583–594
Charpentier X, Oswald E (2004) Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter. J Bacteriol 186:5486–5495
Collazo CM, Galan JE (1997) The invasion-associated type III system of Salmonella typhimurium directs the translocation of Sip proteins into the host cell. Mol Microbiol 24:747–756
Lee VT, Anderson DM, Schneewind O (1998) Targeting of Yersinia Yop proteins into the cytosol of HeLa cells: one-step translocation of YopE across bacterial and eukaryotic membranes is dependent on SycE chaperone. Mol Microbiol 28:593–601
Schnaitman CA (1971) Effect of ethylenediaminetetraacetic acid, Triton X-100, and lysozyme on the morphology and chemical composition of isolate cell walls of Escherichia coli. J Bacteriol 108:553–563
Schnaitman CA (1971) Solubilization of the cytoplasmic membrane of Escherichia coli by Triton X-100. J Bacteriol 108:545–552
Birdsell DC, Cota-Robles EH (1968) Lysis of spheroplasts of Escherichia coli by a non-ionic detergent. Biochem Biophys Res Commun 31:438–446
Esparis-Ogando A, Zurzolo C, Rodriguez-Boulan E (1994) Permeabilization of MDCK cells with cholesterol binding agents: dependence on substratum and confluency. Am J Phys 267:C166–C176
Domingues L, Holden DW, Mota LJ (2014) The Salmonella effector SteA contributes to the control of membrane dynamics of Salmonella-containing vacuoles. Infect Immun 82:2923–2934
Sory MP, Boland A, Lambermont I, Cornelis GR (1995) Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach. Proc Natl Acad Sci U S A 92:11998–12002
Figueira R, Watson KG, Holden DW, Helaine S (2013) Identification of S almonella pathogenicity island-2 type III secretion system effectors involved in intramacrophage replication of S. enterica serovar Typhimurium: implications for rational vaccine design. MBio 4:e00065
Wang RF, Kushner SR (1991) Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. Gene 100:195–199
Domingues L, Ismail A, Charro N, Rodriguez-Escudero I, Holden DW, Molina M, Cid VJ, Mota LJ (2016) The Salmonella effector SteA binds phosphatidylinositol 4-phosphate for subcellular targeting within host cells. Cell Microbiol 18:949–969
Letzelter M, Sorg I, Mota LJ, Meyer S, Stalder J, Feldman M, Kuhn M, Callebaut I, Cornelis GR (2006) The discovery of SycO highlights a new function for type III secretion effector chaperones. EMBO J 25:3223–3233
Diepold A, Amstutz M, Abel S, Sorg I, Jenal U, Cornelis GR (2010) Deciphering the assembly of the Yersinia type III secretion injectisome. EMBO J 29:1928–1940
VanRheenen SM, Luo ZQ, O’Connor T, Isberg RR (2006) Members of a Legionella pneumophila family of proteins with ExoU (phospholipase A) active sites are translocated to target cells. Infect Immun 74:3597–3606
Denecker G, Totemeyer S, Mota LJ, Troisfontaines P, Lambermont I, Youta C, Stainier I, Ackermann M, Cornelis GR (2002) Effect of low- and high-virulence Yersinia enterocolitica strains on the inflammatory response of human umbilical vein endothelial cells. Infect Immun 70:3510–3520
Drecktrah D, Knodler LA, Ireland R, Steele-Mortimer O (2006) The mechanism of Salmonella entry determines the vacuolar environment and intracellular gene expression. Traffic 7:39–51
Acknowledgments
This work was supported by the Unidade de Ciências Biomoleculares Aplicadas—UCIBIO, which is financed by national funds from Fundação para a Ciência e a Tecnologia (FCT) (UID/Multi/04378/2013) and cofinanced by the ERDF under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007728) and by FCT research grants PTDC/BIA-MIC/2821/2012 and PTDC/BIA-MIC/116780/2010. Irina Franco is recipient of apostdoctoral fellowship (SFRH/BPD/102378/2014) from FCT and Sara V. Pais holds a fellowship (PD/BD/52210/2013) within the scope of the PhD program Molecular Biosciences (PD/00133/2012) funded by FCT.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Franco, I.S., Pais, S.V., Charro, N., Mota, L.J. (2017). Effector Translocation Assay: Differential Solubilization. In: Journet, L., Cascales, E. (eds) Bacterial Protein Secretion Systems. Methods in Molecular Biology, vol 1615. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7033-9_35
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7033-9_35
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7031-5
Online ISBN: 978-1-4939-7033-9
eBook Packages: Springer Protocols